Establishing and characterization of human and murine bladder cancer organoids

Neveen Said^{1

2

3}

Affiliations

¹ Cancer Biology Department, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
² Pathology Department, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
³ Urology Department, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Editorial

Neveen Said. Transl Androl Urol. 2019 Jul.

. 2019 Jul;8(Suppl 3):S310-S313.

doi: 10.21037/tau.2019.06.05.

Neveen Said^{1

2

3}

¹ Cancer Biology Department, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
² Pathology Department, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
³ Urology Department, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Mouse and human urothelial cancer organoids: A tool for bladder cancer research.
Mullenders J, de Jongh E, Brousali A, Roosen M, Blom JPA, Begthel H, Korving J, Jonges T, Kranenburg O, Meijer R, Clevers HC. Mullenders J, et al. Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4567-4574. doi: 10.1073/pnas.1803595116. Epub 2019 Feb 20. Proc Natl Acad Sci U S A. 2019. PMID: 30787188 Free PMC article.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34. 10.3322/caac.21551 - DOI - PubMed
1. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013;63:234-41. 10.1016/j.eururo.2012.07.033 - DOI - PubMed
1. Robertson AG, Kim J, Al-Ahmadie H, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 2017;171:540-56.e25. 10.1016/j.cell.2017.09.007 - DOI - PMC - PubMed
1. Sanli O, Dobruch J, Knowles MA, et al. Bladder cancer. Nat Rev Dis Primers 2017;3:17022. 10.1038/nrdp.2017.22 - DOI - PubMed
1. Hermans TJN, Voskuilen CS, van der Heijden MS, et al. Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future. Urol Oncol 2018;36:413-22. 10.1016/j.urolonc.2017.10.014 - DOI - PubMed